We are live on ! Find out more
NHC

Nicholas Hoffman & Company Portfolio holdings

AUM $4.33B
1-Year Est. Return 18.98%
This Fund
S&P 500
This Quarter Est. Return
+7.29%
1 Year Est. Return
+18.98%
3 Year Est. Return
+55.21%
5 Year Est. Return
+46.72%
10 Year Est. Return
+185.29%
AUM
$2.37B
AUM Growth
+$239M
Cap. Flow
+$84.6M
Cap. Flow %
3.57%
Top 10 Hldgs %
75.08%
Holding
301
New
16
Increased
109
Reduced
116
Closed
10

Top Buys

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$26.7M
2
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$24.9M
3
VO icon
Vanguard Morningstar Mid-Cap ETF
VO
+$12.9M
4
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$11.7M
5
VB icon
Vanguard Morningstar Small-Cap ETF
VB
+$5.17M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.85M
2
LLY icon
Eli Lilly
LLY
+$1.49M
3
SGOV icon
iShares 0-3 Month Treasury Bond ETF
SGOV
+$711K
4
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$664K
5
TPL icon
Texas Pacific Land
TPL
+$631K

Sector Composition

Rank Sector Weight
1 Technology 7.31%
2 Financials 7.24%
3 Consumer Staples 1.89%
4 Healthcare 1.61%
5 Consumer Discretionary 1.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LMT icon
76
Lockheed Martin
LMT
$131B
$1.76M 0.07%
3,014
+95
+3% +$51K
MRK icon
77
Merck
MRK
$322B
$1.71M 0.07%
15,068
-1,583
-10% -$188K
ILF icon
78
iShares Latin America 40 ETF
ILF
$3.73B
$1.7M 0.07%
65,717
-518
-0.8% -$13.2K
ORCL icon
79
Oracle
ORCL
$339B
$1.69M 0.07%
9,923
+2,140
+27% +$310K
GSK icon
80
GSK
GSK
$107B
$1.65M 0.07%
40,455
-1,032
-2% -$42.2K
DFUS
81
Dimensional US Equity ETF
DFUS
$20.3B
$1.65M 0.07%
26,503
+1
+0% +$60
MO icon
82
Altria Group
MO
$125B
$1.64M 0.07%
32,182
-1,921
-6% -$97.1K
VUG icon
83
Vanguard Morningstar Growth ETF
VUG
$212B
$1.64M 0.07%
25,560
-900
-3% -$55.8K
BMY icon
84
Bristol-Myers Squibb
BMY
$129B
$1.59M 0.07%
30,691
-1,358
-4% -$63.7K
WFC icon
85
Wells Fargo
WFC
$254B
$1.57M 0.07%
27,781
-528
-2% -$29.9K
NOC icon
86
Northrop Grumman
NOC
$76B
$1.56M 0.07%
2,962
-1
-0% -$490
SSB icon
87
SouthState Bank Corp
SSB
$10.3B
$1.56M 0.07%
16,054
-3,205
-17% -$293K
PYPL icon
88
PayPal
PYPL
$49.9B
$1.55M 0.07%
19,840
-350
-2% -$23.4K
MDLZ icon
89
Mondelez International
MDLZ
$82.9B
$1.53M 0.06%
20,723
-1,585
-7% -$111K
ABBV icon
90
AbbVie
ABBV
$465B
$1.51M 0.06%
7,631
-34
-0.4% -$6.35K
EFV icon
91
iShares MSCI EAFE Value ETF
EFV
$28.3B
$1.5M 0.06%
26,143
– –
SCHB icon
92
Schwab US Broad Market ETF
SCHB
$42.3B
$1.5M 0.06%
67,581
-3,288
-5% -$70.2K
SYK icon
93
Stryker
SYK
$135B
$1.48M 0.06%
4,089
+138
+3% +$47.6K
KMB icon
94
Kimberly-Clark
KMB
$37.6B
$1.46M 0.06%
10,237
-1,269
-11% -$180K
SNY icon
95
Sanofi
SNY
$107B
$1.44M 0.06%
25,014
-682
-3% -$36.8K
UNH icon
96
UnitedHealth
UNH
$382B
$1.44M 0.06%
2,461
+14
+0.6% +$7.92K
GPC icon
97
Genuine Parts
GPC
$17.9B
$1.43M 0.06%
10,253
-312
-3% -$43.3K
FNDE icon
98
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
$9.46B
$1.43M 0.06%
44,206
+27,558
+166% +$824K
MDT icon
99
Medtronic
MDT
$112B
$1.42M 0.06%
15,767
-6
-0% -$505
CL icon
100
Colgate-Palmolive
CL
$74.8B
$1.42M 0.06%
13,666
-871
-6% -$88.8K
2 3
4
5 6

Similar funds

Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
NEI
Northwest & Ethical Investments Toronto, Ontario, Canada $4.32B AUM 23.26% 1-Year Est. Return
B
Bailard Foster City, California $4.35B AUM 23.57% 1-Year Est. Return
Kovitz Investment Group Partners
Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return
MYIA
Mount Yale Investment Advisors Denver, Colorado $4.31B AUM 21.13% 1-Year Est. Return
GWM
Geneos Wealth Management Englewood, Colorado $4.31B AUM 18.36% 1-Year Est. Return
IUHSA
Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return
CW
CreativeOne Wealth Overland Park, Kansas $4.31B AUM 19.42% 1-Year Est. Return

Nicholas Hoffman & Company's Q3 2024 Portfolio in Review

As of Q3 2024, Nicholas Hoffman & Company held 301 positions worth $2.37B, up 11% from $2.13B the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Nicholas Hoffman & Company deployed $84.6M of net new capital in Q3 2024, opening 16 new positions and adding to 109 existing holdings. Its largest new stake was Zimmer Biomet: 9,844 shares worth $1.06M.

By sector, the portfolio is most concentrated in Technology at 7.3% of assets, down from 7.8% a quarter earlier, followed by Financials and Consumer Staples.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.85M trimmed.

  • Nicholas Hoffman & Company's largest Q3 2024 buy was Zimmer Biomet: 9,844 shares worth $1.06M.
  • Nicholas Hoffman & Company added most to Vanguard S&P 500 ETF in Q3 2024, an estimated $26.7M increase.
  • Nicholas Hoffman & Company's biggest Q3 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.85M.
  • Nicholas Hoffman & Company fully exited Novo Nordisk in Q3 2024, selling an estimated $496K.
  • Nicholas Hoffman & Company's ten largest holdings make up 75% of its $2.37B portfolio in Q3 2024.
  • Nicholas Hoffman & Company opened 16 new positions and closed 10 in Q3 2024.
  • Nicholas Hoffman & Company's portfolio value rose 11% quarter-over-quarter to $2.37B.

Based on Nicholas Hoffman & Company's 13F filing for Q3 2024, filed 25 Oct 2024.